Feb 21, 2020
FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome
Feb 21, 2020
Special Learning, Inc. Joins a California Grant Consortium to Help Individuals Obtain Education and Find Employment Opportunities in the Autism and Special Needs Field
Feb 12, 2020
Houston Museum of Natural Science Is Now A Certified Autism Center(TM)
Feb 11, 2020
Innovative Listening Training for Autism Has Transformative Potential
Feb 04, 2020
MeBe Opens San Diego Learning Center for Children with Autism and Special Needs
Feb 03, 2020
Researchers use Virtual Reality to Teach Street-Crossing Skills to Children with Autism
Feb 03, 2020
Autism Employer auticon raises $2.95M for North American Growth
Jan 28, 2020
Autism Therapy Provider Opening Four New Minnesota Treatment Centers in Early 2020
Jan 27, 2020
Fragile X Syndrome (FXS): Current Treatment Practices, Emerging Drugs, Market Share of Individual Therapies, Current & Forecasted Market Size from 2017 to 2028 Segmented by 7 Major Markets
Jan 24, 2020
Fraser Podcast Brings Expert Advice to Busy Families
Jan 23, 2020
CARD Secures Updated Guidance Ensuring Mental Health Parity for Medi-Cal Children
Jan 23, 2020
Largest Autism Sequencing Study to Date Identifies 102 Genes Associated With the Condition
Jan 17, 2020
Leading Provider of Applied Behavior Analysis for Autism Announces New Location in Houston, Texas
Jan 13, 2020
Global Autism Clinical Trials Review H2, 2019 - Top Level Data by Trial Status, Trial Phase, Sponsor Type, End Point Status, Region and Country
Dec 19, 2019
Organization for Autism Research Launches Employment Program Nationwide Expansion
Dec 16, 2019
The New England Center for Children Opens Clinic for Autism Services in Dubai
Dec 12, 2019
Trellis School launches their new Middle and High School Program in Sparks, MD
Dec 12, 2019
Trumpet Shares 2019 Progress and Plans for Further Expansion in 2020
Dec 04, 2019
Quadrant Biosciences Launches First Ever Epigenetic Saliva Test for Autism
Dec 02, 2019
Therapix Biosciences Announces the Continued Development of THX-210 ("RESPECTRUM") Cannabinoids Based Treatment for Autism Spectrum Disorder